FDA approving cancer drugs that don't extend lifespan, although they do extend progression-free time of tumors -- at the expense of quality of life.

http://www.medpagetoday.com/special-reports/s...lope/55170

Good that Kevetrin seems to have few bad side effects, isn't it? I think that more attention is going to be paid to quality of life as boomers start aging in to cancer diagnoses. Boomers have seen their parents suffer and are not going to want to have those same side effects if it isn't going to extend lifespan significantly.

That article just shows how much Kevetrin is needed.